Published in J Am Coll Cardiol on December 01, 1999
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem (2005) 1.72
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev (2012) 1.61
Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol (2007) 1.25
Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol (2007) 1.13
Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI). Cardiovasc Diabetol (2007) 1.06
Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy. Curr Cardiol Rev (2010) 1.03
Interaction of diet and diabetes on cardiovascular function in rats. Am J Physiol Heart Circ Physiol (2008) 0.96
Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol (2012) 0.94
Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res (2011) 0.90
Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents. J Mol Cell Cardiol (2009) 0.89
Low Intensity Physical Exercise Attenuates Cardiac Remodeling and Myocardial Oxidative Stress and Dysfunction in Diabetic Rats. J Diabetes Res (2015) 0.89
Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol (2008) 0.88
Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study. Cardiovasc Diabetol (2007) 0.85
Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Exp Clin Cardiol (2011) 0.85
Combination of a peroxisome proliferator-activated receptor-gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats. J Diabetes Investig (2013) 0.84
The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes. Cardiovasc Diabetol (2014) 0.84
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation (2016) 0.84
The afterload-dependent peak efficiency of the isolated working rat heart is unaffected by streptozotocin-induced diabetes. Cardiovasc Diabetol (2014) 0.83
Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type II diabetic mice. BMC Cardiovasc Disord (2014) 0.82
Updating experimental models of diabetic cardiomyopathy. J Diabetes Res (2015) 0.80
Caveolins in cardioprotection - translatability and mechanisms. Br J Pharmacol (2015) 0.80
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. Cardiovasc Diabetol (2015) 0.80
Streptozotocin-induced diabetes prolongs twitch duration without affecting the energetics of isolated ventricular trabeculae. Cardiovasc Diabetol (2014) 0.80
Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease. Am J Nucl Med Mol Imaging (2014) 0.79
Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Br J Pharmacol (2006) 0.79
Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging. BMC Cardiovasc Disord (2015) 0.77
Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart. Am J Physiol Heart Circ Physiol (2016) 0.77
Hyperglycemia-Induced Hypovolemia Is Involved in Early Cardiac Magnetic Resonance Alterations in Streptozotocin-Induced Diabetic Mice: A Comparison with Furosemide-Induced Hypovolemia. PLoS One (2016) 0.76
HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy. PPAR Res (2016) 0.76
Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. PLoS One (2014) 0.75
Of mice and men: modeling cardiovascular complexity in diabetes. Focus on "Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart". Am J Physiol Cell Physiol (2014) 0.75
Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim (2014) 0.75
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med (2000) 3.76
Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA (1998) 3.66
The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J (2000) 3.64
Stimulus-specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein. J Physiol (1984) 2.72
Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med (1993) 2.55
Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol (1995) 2.52
Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med (2000) 2.52
Elevated imposed work of breathing masquerading as ventilator weaning intolerance. Chest (1995) 2.38
Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med (1995) 2.27
ACC expert consensus document. Radiation safety in the practice of cardiology. American College of Cardiology. J Am Coll Cardiol (1998) 2.22
Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med (1992) 2.11
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet (2000) 2.07
Vascular smooth muscle: the first recorded Ca2+ transients. Pflugers Arch (1982) 2.00
Atrial ejection force: a noninvasive assessment of atrial systolic function. J Am Coll Cardiol (1993) 1.99
Exaggerated heart rate oscillations during two meditation techniques. Int J Cardiol (1999) 1.93
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol (1996) 1.75
Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci (2000) 1.71
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation (2000) 1.69
The Jamaica ginger paralysis. JAMA (1982) 1.64
Alteration of cytoplasmic ionized calcium levels in smooth muscle by vasodilators in the ferret. J Physiol (1984) 1.62
Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A (1995) 1.61
Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol (1994) 1.61
Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A (1997) 1.59
Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol (2000) 1.59
Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest (1990) 1.54
Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation (1994) 1.50
Creatinine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy. J Am Coll Cardiol (1992) 1.49
Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol (1995) 1.48
Transesophageal echocardiography and atrial fibrillation: added value or expensive toy? Ann Intern Med (1998) 1.47
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Ann Intern Med (1998) 1.45
Intracellular Ca2+ transients in the cat papillary muscle. Can J Physiol Pharmacol (1982) 1.45
Differential activation of myofibrils during fatigue in phasic skeletal muscle cells. J Muscle Res Cell Motil (1991) 1.44
Evidence for 2-hydroxy-4(methylthio) butanoic acid and DL-methionine having different dose responses in growing broilers. Poult Sci (2006) 1.43
Jamaica ginger paralysis. Forty-seven-year follow-up. Arch Neurol (1978) 1.43
Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res (1989) 1.39
Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation (1996) 1.38
Method for non-invasively recording electrocardiograms in conscious mice. BMC Physiol (2001) 1.38
Osteochondrosis of the shoulder joint of the horse. Cornell Vet (1981) 1.38
Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease. Ann N Y Acad Sci (1971) 1.36
Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol (1999) 1.32
A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice. Blood (2000) 1.31
The ACC professional life survey: career decisions of women and men in cardiology. A report of the Committee on Women in Cardiology. American College of Cardiology. J Am Coll Cardiol (1998) 1.29
Applied physiology of triathlon. Sports Med (1995) 1.28
Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol (1998) 1.28
In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol (1994) 1.25
Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation (2000) 1.24
Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res (1985) 1.23
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse (1986) 1.21
Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation (1989) 1.18
Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol (1999) 1.18
Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells. J Physiol (1998) 1.17
Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proc Natl Acad Sci U S A (1998) 1.16
Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J (1996) 1.15
Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels. Proc Natl Acad Sci U S A (2001) 1.13
Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation (2000) 1.12
Alterations in contractility and intracellular Ca2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res (1993) 1.11
Clinical trials and tribulations. Arch Intern Med (1974) 1.11
Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology (1996) 1.09
Stretch-induced VEGF expression in the heart. J Clin Invest (1997) 1.08
Regulation by molluscan myosins. Mol Cell Biochem (1999) 1.08
Absorption and metabolism of L-dopa by the human stomach. Eur J Clin Invest (1971) 1.07
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest (1991) 1.06
Loop I can modulate ADP affinity, ATPase activity, and motility of different scallop myosins. Transient kinetic analysis of S1 isoforms. Biochemistry (1998) 1.06
Use of transoesophageal echocardiography to detect left atrial thrombi before percutaneous balloon dilatation of the mitral valve: a prospective study. Br Heart J (1992) 1.05
Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation (1995) 1.05
Abnormal Cai2+ handling is the primary cause of mechanical alternans: study in ferret ventricular muscles. Am J Physiol (1991) 1.05
Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle. Circ Res (1988) 1.05
Use of heart rate monitors by endurance athletes: lessons from triathletes. J Sports Med Phys Fitness (1998) 1.05
Temozolomide in the management of dopamine agonist-resistant prolactinomas. Clin Endocrinol (Oxf) (2012) 1.05
Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest (1992) 1.04
Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med (1999) 1.04
Left ventricular function is not impaired in weight-lifters who use anabolic steroids. J Am Coll Cardiol (1992) 1.04
Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. Am J Physiol Heart Circ Physiol (2000) 1.03
Epiphyseal plate injury in the dog: a radiographic study of growth disturbance in the forelimb. J Small Anim Pract (1971) 1.03
Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03
Effect of increased body mass index on accuracy of two-dimensional echocardiography for measurement of left ventricular volume, ejection fraction, and mass. Am J Cardiol (2001) 1.03